## Oculomotor Nerve (CN III) — Most Common Ischemic Cranial Neuropathy ### Clinical Presentation Analysis **Key Point:** The combination of **ptosis, pupillary dilation, and impaired eye adduction** is pathognomonic for oculomotor nerve (CN III) palsy. This is the most common cranial nerve affected by ischemic stroke. ### Anatomy of CN III and Its Vulnerabilities | Feature | Detail | |---------|--------| | **Nuclei location** | Midbrain (interpeduncular fossa) | | **Fascicular course** | Passes through cerebral peduncle; vulnerable to Weber's syndrome | | **Subarachnoid course** | Longest intracranial course (80 mm); crosses cavernous sinus | | **Blood supply** | Penetrating branches from PCA and SCA; watershed zone | | **Vascular territory** | Supplied by perforating branches — susceptible to small-vessel disease | **Clinical Pearl:** CN III has the longest intracranial course of any cranial nerve, making it the most vulnerable to ischemic injury, particularly in patients with diabetes, hypertension, and age >50 years. ### CN III Palsy: Motor and Parasympathetic Components **High-Yield:** CN III innervates: 1. **Somatic motor** (via fascicles in nerve trunk): - Medial rectus (adduction) - Superior rectus (elevation) - Inferior rectus (depression) - Inferior oblique (elevation + abduction) - Levator palpebrae superioris (eyelid elevation) 2. **Parasympathetic** (preganglionic fibers in dorsomedial fascicles): - Pupillary constrictor (via ciliary ganglion) - Ciliary muscle (accommodation) ### Clinical Features of CN III Palsy | Sign | Mechanism | |------|----------| | **Ptosis** | Loss of levator palpebrae function | | **Pupillary dilation** | Loss of parasympathetic pupillary constriction | | **"Down and out" eye** | Unopposed action of CN IV (superior oblique) and CN VI (lateral rectus) | | **Diplopia** | Vertical and horizontal misalignment | | **Loss of accommodation** | Ciliary muscle paralysis | ### Ischemic vs. Compressive CN III Palsy | Feature | Ischemic (Microvascular) | Compressive (Tumor/Aneurysm) | |---------|--------------------------|-----------------------------| | **Pupil involvement** | Typically spared (pupil-sparing CN III) | Dilated pupil (early sign) | | **Onset** | Sudden | Gradual | | **Progression** | Maximal at onset | Progressive | | **Associated findings** | Diabetes, HTN, age >50 | Headache, mass effect | | **MRI/CTA** | Normal or small infarct | Lesion visible | | **Prognosis** | Good recovery (weeks–months) | Depends on etiology | **Mnemonic: CN III PALSY** — **C**ranial nerve **III**, **P**upil dilated, **A**dduction lost, **L**evator weak (ptosis), **S**uperior rectus weak, **Y**—down and out eye ### Why CN III is Most Commonly Affected by Stroke 1. **Longest intracranial course**: 80 mm from midbrain to cavernous sinus — maximum exposure to ischemia. 2. **Penetrating artery territory**: Supplied by small perforating branches from PCA and SCA, which are prone to occlusion in small-vessel disease. 3. **Watershed vulnerability**: The nerve passes through areas with tenuous collateral circulation. 4. **Epidemiology**: CN III ischemic palsy accounts for ~50% of all acute cranial nerve palsies in stroke patients. ### Differential Diagnosis of Acute Ophthalmoplegia ```mermaid flowchart TD A[Acute ophthalmoplegia]:::outcome --> B{Pupil involvement?}:::decision B -->|Dilated pupil| C[CN III palsy]:::action B -->|Normal pupil| D[Pupil-sparing CN III]:::action C --> E{Sudden onset + risk factors?}:::decision E -->|Yes: age, DM, HTN| F[Ischemic stroke - MRI]:::action E -->|No: gradual + headache| G[Compressive lesion - CTA/MRI]:::urgent D --> H{Down and out eye?}:::decision H -->|Yes| I[CN III involvement]:::outcome H -->|No| J{Lateral rectus weakness?}:::decision J -->|Yes| K[CN VI palsy]:::outcome J -->|No| L[CN IV palsy]:::outcome ``` ### Management of Ischemic CN III Palsy 1. **Neuroimaging**: MRI brain with DWI/PWI to confirm acute ischemia; CTA head/neck to exclude aneurysm if pupil dilated. 2. **Stroke protocol**: Thrombolysis (if within 4.5 hours) or thrombectomy (if large vessel occlusion). 3. **Risk factor modification**: Aspirin, statin, blood pressure control, glycemic control. 4. **Eye care**: Lubricating drops, eye taping, protective glasses to prevent corneal ulceration. 5. **Prognosis**: Most ischemic CN III palsies recover within 3–6 months with supportive care. **High-Yield:** The presence of pupillary dilation in CN III palsy suggests ischemic etiology (microvascular stroke in elderly/diabetic patients) rather than compressive lesion, which typically presents with gradual onset and other mass effect signs.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.